Cantor Fitzgerald Reiterates Overweight on Teradyne, Maintains $550 Price Target
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsReiterationPrice TargetHot
Cantor Fitzgerald analyst C.J. Muse reiterates Teradyne (NASDAQ:TER) with a Overweight and maintains $550 price target.
Cantor Fitzgerald analyst C.J. Muse reiterates Teradyne (NASDAQ:TER) with a Overweight and maintains $550 price target.